Exenatide improves postprandial hyperglycemia and dyslipidemia in metformin treated patients with type 2 diabetes

被引：0
|
作者：
Bunck, Mathijs C.
Corner, Anja
Diamant, Michaela
Eliasson, Bjorn
Malloy, Jaret L.
Shaginian, Rimma M.
Ding, Wei
Kendall, David M.
Smith, Ulf
Yki-Jarvinen, Hannele
Heine, Robert J.
Taskinen, Marja-Ritta
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A33 / A33
页数：1
相关论文
共 50 条
  • [31] Discontinuation of metformin in type 2 diabetes patients treated with insulin
    Wulffelé, MG
    Kooy, A
    Lehert, P
    Bets, D
    Oom, JA
    van der Burg, BB
    Donker, AJM
    Stehouwer, CDA
    NETHERLANDS JOURNAL OF MEDICINE, 2002, 60 (06): : 249 - 252
  • [32] METOCLOPRAMIDE AS A RISK FACTOR FOR POSTPRANDIAL HYPERGLYCEMIA IN TYPE 2 DIABETES
    Gutierrez-Hermosillo, H.
    Diaz de Leon-Gonzalez, E.
    Beltran Santiago, D.
    Armando Cedillo-Rodriguez, J.
    Gutierrez Hermosillo, V.
    Tamez-Perez, H. E.
    NUTRICION HOSPITALARIA, 2012, 27 (04) : 1267 - 1271
  • [33] Postprandial hyperglycemia in type 2 diabetes and obstructive sleep apnea
    Aurora, R. Nisha
    Punjabi, Naresh M.
    SLEEP MEDICINE, 2021, 84 : 173 - 178
  • [34] Type 2 diabetes: postprandial hyperglycemia and increased cardiovascular risk
    Aryangat, Ajikumar V.
    Gerich, John E.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2010, 6 : 145 - 155
  • [35] Safety of Exenatide Once Weekly in Patients with Type 2 Diabetes Treated with a Thiazolidinedione
    Norwood, Paul
    Pintilei, Ella
    Pop, Lavinia
    Liutkus, Joanne
    Choi, Suktae
    Giaconia, Joseph
    Trautman, Michael
    DIABETES, 2010, 59 : A195 - A195
  • [36] Comparison of Exenatide and Metformin Monotherapy in Overweight/Obese Patients with Newly Diagnosed Type 2 Diabetes
    Liu, Jia
    Hu, Yanjin
    Xu, Yuan
    Jia, Yumei
    Miao, Li
    Wang, Guang
    INTERNATIONAL JOURNAL OF ENDOCRINOLOGY, 2017, 2017
  • [37] Exenatide: A guide to its use as an adjunct to metformin and/or a sulfonylurea in patients with type 2 diabetes mellitus
    不详
    Drugs & Therapy Perspectives, 2007, 23 (10) : 5 - 8
  • [38] Exenatide - A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and/or a sulfonylurea)
    Cvetkovic, Risto S.
    Plosker, Greg L.
    DRUGS, 2007, 67 (06) : 935 - 954
  • [39] Metformin enhances secretion of GLP-1 but not GIP and improves postprandial glucose excursion in Japanese patients with type 2 diabetes
    Kuwata, H.
    Yabe, D.
    Sugawara, K.
    Usui, R.
    Sugizaki, K.
    Kitamoto, Y.
    Fujiwara, S.
    Watanabe, K.
    Hyo, T.
    Murakami, T.
    Yamaguchi, T.
    Shimizu, S.
    Eto, H.
    Kurose, T.
    Seino, Y.
    DIABETOLOGIA, 2012, 55 : S97 - S97
  • [40] Safety and efficacy of exenatide in patients with type 2 diabetes mellitus using thiazolidenediones with or without metformin
    Zinman, Bernard
    Hoogwerf, Byron
    Garcia, Santiago Duran
    Milton, Denai
    Giaconia, Joseph
    Kim, Dennis
    Trautmann, Michael
    Brodows, Robert
    DIABETES, 2006, 55 : A28 - A28
12345